Cancer Care's Road to Recovery from the Global Pandemic

One serious, unwanted side effect of the COVID-19 pandemic is the potential for "substantial" consequences for cancer outcomes due to delayed access to cancer diagnosis and treatment. Hear from the author of a study that detected a substantial decrease (among American seniors) in cancer screenings, visits, therapy, and surgeries. The study concluded that—if left unaddressed—these decreases and delays in identifying new cancers and in treatment delivery would increase cancer morbidity and mortality for years to come.  Guest: Debra Patt, MD, PhD, MBA, FASCO Executive Vice President, Public Policy and Strategic Initiatives Texas Oncology Related Content: ASCO Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care ACCC 38th [Virtual] National Oncology Conference [PODCAST] Ep 47: Telehealth after COVID-19 Telemedicine and Cancer Care: Today's Learnings for a Post-Pandemic World [PODCAST] Ep 56: What Comes Next for Telehealth? [BLOG] Managing COVID+ Oncology Patients at Home During Treatment [BLOG] Extending Telehealth Beyond the Pandemic Telehealth Resource Library [MINI-PODCAST] Ep 64: A Summer of Disconnect for Cancer Professionals [MINI-PODCAST] Ep 67: Coping with Pandemic Grief